AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05333757 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Adults with spinal deformities were asked to complete two questionnaires assessing quality of life
Study NCT05436041 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Collaborative Diet Goal Setting Clinical Decision Support
Description: Receives Nutri
Study NCT04526132 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Felbinac Trometamol Injection
Description: Felbinac Trometamol Injection diluted to 100 ml with 0.9% sodium chloride injection.Use a micro-injection pump to inject intravenously at a constant speed for 30 min (± 2 min)..~One dose at 8h、16h 、24h、32h and 40h after the start of the first dose,the first intravenous infusion was started at the end of the operation (Skin suture completes the last stitch).The drug was given 6 times,3 times/day,once every 8 hours.
Study NCT04526132 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: Placebo diluted to 100 ml with 0.9% sodium chloride injection.Use a micro-injection pump to inject intravenously at a constant speed for 30 min (± 2 min).~One dose at 8h、16h 、24h、32h and 40h after the start of the first dose,the first intravenous infusion was started at the end of the operation (Skin suture completes the last stitch).The drug was given 6 times,3 times/day,once every 8 hours.
Study NCT05425082 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Motor relearning program
Description: Treatment session of one hour per day for five days a week, for four weeks for each participant until 20 sessions
Study NCT05425082 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurodevelopmental therapy
Description: Treatment session of one hour per day for five days a week, for four weeks for each participant until 20 sessions.
Study NCT05276726 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JAB 21822
Description: Administered orally
Study NCT05621109 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Description: Subjects will receive very low-calorie diet for 8-10 weeks to introduce a rapid weight loss of approximately 10%. Once target weight is achieved, participants will be reintroduced to foods to introduce weight stability.~The male will follow the maternal randomization, i.e. weight loss if BMI ≥25 until a BMI of 23 or a weight loss of approximately 10% is obtained.~During weight loss maintenance, subjects will receive dietary counseling to follow a diet high in protein (corresponding to 22-25E%), high fiber and wholegrain while fulfilling the requirements for essential fatty acids, micronutrients and trace elements in accordance with Nordic Nutrition Recommendations (NNR) 2012.~Throughout the study period participants will be encouraged to follow the official recommendations for physical activity as recommended by the Danish health authorities 2022.
Study NCT04774484 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training
Description: After the acclimatization session and assessment of eligibility, a graded exercise test (GXT) will be given to the participant. After checking their vitals, the HIIT program will be performed on recumbent cycles. The first two weeks of training will consist of a gradual ramp where subjects will perform a moderate intensity cycling program consisting of a 5-minute warm up followed by progressively longer continuous cycling starting at 15 minutes and progressing up to 30 minutes prior to starting the HIIT training. For the HIIT training subjects will perform 5 minutes of low to moderate steady state cycling to warm up. Following the warm up, the subjects will complete the 4x4 HIIT program. This will consist of 4 minutes of cycling at 85% of the subject's maximum heart rate (HR) followed by 4 minutes of a low intensity cycling period for recovery.
Study NCT06443437 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: bee-buzzy vibrating cold application marionette doll
Description: * Bee-buzzy will be attached to the arm of the preschool child (who is included in the bee-buzzy group) by the researchers, where the phlebotomy will be performed on the child. It reduces pain through its cold wings and vibration. It helps to distract attention during phlebotomy and reduces the feeling of pain and fear. Bee-buzzy will be tied 5 cm above the area from which blood will be drawn, and after waiting for 15 seconds, the nurse will perform a phlebotomy.~* A marionette doll group; while the nurse is going to perform the phlebotomy operation on the preschool child, one of the researchers will try to distract the child by paly with marionette doll. The researchers will receive training in play therapy
Study NCT06443437 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: bee-buzzy vibrating cold application marionette doll
Description: * Bee-buzzy will be attached to the arm of the preschool child (who is included in the bee-buzzy group) by the researchers, where the phlebotomy will be performed on the child. It reduces pain through its cold wings and vibration. It helps to distract attention during phlebotomy and reduces the feeling of pain and fear. Bee-buzzy will be tied 5 cm above the area from which blood will be drawn, and after waiting for 15 seconds, the nurse will perform a phlebotomy.~* A marionette doll group; while the nurse is going to perform the phlebotomy operation on the preschool child, one of the researchers will try to distract the child by paly with marionette doll. The researchers will receive training in play therapy
Study NCT06443437 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Rotuine care
Description: children in control group will receive routine hospital are
Study NCT05998304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C] Yiqibuvir
Description: 600 mg suspension containing 100µCi of \[14C\] Yiqibuvir
Study NCT05567926 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Beetroot juice concentrate (140 ml)
Description: A beetroot juice concentrate (140 ml) will be administered to participants in experimental conditions.
Study NCT05567926 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Blackcurrant juice (placebo)
Description: 140 ml of blackcurrant juice with added appropriate amount of sugar to equalize the carbohydrate value and lemon juice fort the taste.
Study NCT04682392 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Delfi's PTS Personalized Tourniquet System for Blood Flow Restriction Group
Description: A Delphi Personal Tourniquet system for blood flow restriction (BFR) therapy will be applied to each treatment session for this group. They will do 3-5 exercises with the BFR system on the surgical or both lower extremities for bilateral or unilateral movements.
Study NCT04682392 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard ACL rehab
Description: Standard accelerated ACL protocol
Study NCT06204081 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CSO_without cueing
Description: The sole is worn without using the cueing application
Study NCT06204081 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CSO_cueing
Description: The sole is worn with using the cueing application
Study NCT05254249 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lactobacillus Plantarum IS-10506
Description: Indonesian original probiotic, given in capsule form with a dose of 2 x 1010 CFU
Study NCT06052046 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TOTAL30 for Astigmatism Contact Lenses
Description: Participants will be refit into TOTAL30 for Astigmatism Contact Lenses and followed for 1 month.
Study NCT05254249 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is an empty drug, given in capsule form with a dose of 2x1 sachets
Study NCT05027152 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance training
Description: The resistance training group will perform traditional resistance exercises with an intensity of 30%-60% of a voluntary repetition maximum and 1 to 2 sets of 10 repetitions each exercise. The repetitive task training group will carry out exercises involving upper and lower limbs.
Study NCT05027152 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Repetitive task training
Description: The repetitive task training group will carry out exercises involving upper and lower limbs.
Study NCT04877847 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low-frequency therapeutic ultrasound (LOTUS)
Description: Participants will wear low-frequency therapeutic ultrasound system for procedure. Device will be turned on per normal operating instructions.
Study NCT04877847 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: LOTUS System with Ultrasound Disabled
Description: Participants will wear low-frequency therapeutic ultrasound system for procedure. Device will be turned on and set to Control Setting.
Study NCT06196294 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cell therapy for solid tumors
Description: Transfer γδT cells into patients for anti-ancer therapy.
Study NCT05630417 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Feet and Back Massage
Description: Foot massage: Feet are the most neglected organs of people and therefore cause many complaints. Foot massage is a massage applied to the back of the foot, toes, soles of the feet, the muscles between the thumb and little fingers, and the heel, where the muscles between the metatarsal bones are located.~Back massage: Back massage is a non-invasive nursing intervention that can be easily applied by nurses. In back massage application; A 10-minute back massage program applied by Çınar and Eşer (2012) will be applied.
Study NCT05895201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Description: 600 or 400 (or MTD) mg PO every 12 hours on days -1 to +14 depending on dose level assignment.
Study NCT05895201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: 1.3 or 1.0 mg/m2 (or MTD) IV push 6 hours after graft infusion completion (day 0), and 72 hours thereafter depending on dose level assignment.
Study NCT05895201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: 50 mg/kg IV over 1 hour on days +3 and +4
Study NCT06453499 — intervention group
Intervention type: OTHER
Intervention: Physical therapy
Description: ultrasound for 5 minutes,Tens and hot packs for 20 minutes, back exercise
Study NCT05296564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CYCLOPHOSPHAMIDE and FLUDARABIN
Description: 1. CYCLOPHOSPHAMIDE 250 mg/msq, Day -5,-4,-3 with FLUDARABIN 25 mg/msq, Day -5,-4,-3
Study NCT05296564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: CYCLOPHOSPHAMIDE 250 mg/msq, Day -6, -5,-4,-3
Study NCT05473312 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 28-day PD/Hearth Sessions
Description: Mothers will come together in a home-like setting to rehabilitate their malnourished child (8 dyads/Hearth), learn and practice new feeding and childcare behaviours (during Covid-19: 4 dyads/Hearth). Curriculum and activities will be informed by CAC, CORE Guide and formative research. Two female facilitators will demonstrate, encourage, convey key messages and guide practices.
Study NCT05473312 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supplemental Print Information
Description: The content will be informed by the formative research and CAC, will reinforce Hearth messages, and be adapted for each gender group. Material will be locally produced, engaging, user friendly, and target an illiterate audience (i.e. culturally relevant images with minimal text).
Study NCT04974658 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Inter-semispinal plane block
Description: Ultrasound Inter-semispinal plane block in block group
Study NCT05707819 — intervention group
Intervention type: DRUG
Intervention: Sintilimab (PD-1 Antibody)
Description: Patients will receive 3 cycles of induction chemotherapy with gemcitabine and cisplatin and concurrent cisplatin-radiation plus Sintilimab, and then receive 11 cycles of Sintilimab after intensity-modulated radiotherapy (IMRT). All patients will receive IMRT. Sintilimab will begin on day 1 of induction chemotherapy and continue every 3 weeks for 17 cycles.
Study NCT04790214 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CHF Patients
Description: Cardiac rehabilitation program on CHF patients on 06-08 weeks. Program will include: physical aerobic re-training, therapeutic education on CHF, psychological follow-up, nutritional education
Study NCT06036940 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Preoperative patient education given with three different methods
Description: To determine the effect of preoperative patient education given by three different methods on the level of perioperative anxiety in children aged 4-7 years.
Study NCT02207127 — intervention group
Intervention type: PROCEDURE
Intervention: MRI, DISE, and Surgery
Description: MRI, DISE, and Surgery
Study NCT05289869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High-dose oxytocin
Description: Starting dose 6 mU/min and increased by 6 mU/min every 30 minutes until adequate contractions achieved, at the discretion of the obstetric providers.
Study NCT05289869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low-dose oxytocin
Description: Starting dose 2 mU/min and increased by 2 mU/min every 30 minutes until adequate contractions achieved, at the discretion of the obstetric providers.
Study NCT05430646 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Covered metal ureteral stents
Description: The CMUS is a fully covered, self-expanding, large caliber metal stent. The stent is made of super-elastic nickel-titanium alloy, which maintain lumen patency via providing long-term direct wall support.
Study NCT05430646 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tandem DJ stents
Description: Tandem DJ stents represents for two stents side-by-side, which improves the urine flow by better withstanding the compressive tumoral forces and allowing urine to flow between the stents.
Study NCT01041144 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: lifestyle counseling
Description: supporting diabetes patients using Internet communication
Study NCT04974658 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Inter-semispinal plane block
Description: Ultrasound Inter-semispinal plane block in block group
Study NCT04967573 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Description: Rivaroxaban 20 mg or 10 mg for 3 months
Study NCT04967573 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rivaroxaban
Description: Rivaroxaban 20 mg or 10 mg for 3 months
Study NCT05049850 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imlifidase
Description: Imlifidase is an immunoglobulin G (IgG)-degrading enzyme of Streptococcus pyogenes that is highly specific for IgG.
Study NCT05017246 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: -Epidural bupivacaine 0.1% 2-6ml/hr based on MAP within 10% of patient's baseline MAP
Study NCT05017246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Morphine
Description: -Preservative-free intrathecal morphine (duramorph) 150mcg injection (0.15ml or a 0.5mg/0.5ml prepared solution)
Study NCT05017246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine
Description: -Lidocaine infusion 1 mg/kg ideal body weight (IBW)
Study NCT05296564 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HBI 0201-ESO TCRT
Description: HBI 0201-ESO TCRT will be infused on Day 0, after lymphodepletion. Three dose levels will be evaluated: 1x10E9, 5x10E9 and 1x10E10.
Study NCT05296564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aldesleukin
Description: Continuous infusion of aldesleukin 18x10E6 IU/24h will be given 24 hours post HBI 0201-ESO TCRT infusion, for four days or until a dose limiting toxicity will occur that mimics cytokine release syndrome (CRS) including blood pressure drop, oliguria or confusion- all of them or any one alone.
Study NCT06342453 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Art Therapy
Description: Participate in CrA
Study NCT06342453 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Discussion
Description: Participate in art focus group, art-making
Study NCT06342453 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Media Intervention
Description: Watch videos
Study NCT06342453 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Survey Administration
Description: Ancillary studies
Study NCT06342453 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies
Study NCT05308433 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Functional MRI
Description: The volunteer will have to imagine the smells evoked by different visual aids. This task will be carried out during 2 acquisition runs of about 10 minutes each. The volunteer should note (on a scale from 1 to 4) the pleasantness of the smell evoked.
Study NCT05308433 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality: control
Description: The volunteer will be immersed in a virtual maritime environment with nauseating characteristics. In the center of the maritime scene, it will be visible the black outlines of a frame. Every minute, the volunteer will be asked to verbalize the level of his general condition via the Fast Motion Sickness Scale (1 to 20).
Study NCT05308433 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality: experimental
Description: The volunteer will be immersed in a virtual maritime environment with nauseating characteristics. The visual support inserted in the center of the virtual scene will be the one defined as being the most facilitator of the olfactory imagination during the fMRI examination. The volunteer will be asked to concentrate on the smell evoked by this support. Every minute, the volunteer will be asked to verbalize the level of his general condition via the Fast Motion Sickness Scale (1 to 20).
Study NCT06579625 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Cancer education
Description: Participants in the experimental group will receive cancer education.
Study NCT05582798 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alpha 1-Proteinase Inhibitor 180mg/kg
Description: alpha1-proteinase inhibitor (human) intravenous infusion
Study NCT05582798 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alpha 1-Proteinase Inhibitor 120mg/kg
Description: alpha1-proteinase inhibitor (human) intravenous infusion
Study NCT05311371 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breathing exercise group
Description: The exercise was applied in accordance with the Guideline on Breathing Exercise for Reducing Nausea and Vomiting prepared by the researcher in accordance with the literature. In addition, the researcher has a breath coaching certificate. The guideline include the application steps of breathing exercise. First, the researcher will demonstrate to the patients the practice of breathing exercise in accordance with the guideline. In the next step, patients they will be asked to do this application on themselves. The training is planned to take about 15-20 minutes for each patient. This guide will be given to patients after the training. They will be asked to do this breathing exercise correctly and effectively in accordance with the guideline for at least 5 min in case of sensation of nausea and vomiting for 14 days. The researcher will follow up the patients for 14 days by visiting room them every day.
Study NCT05582798 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sodium chloride
Description: Sodium chloride 09.% intravenous infusion
Study NCT05131672 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: open reduction and internal fixation (ORIF)
Description: open reduction and internal fixation with pin or screw fixation
Study NCT05131672 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cast immobilization
Description: immobilization in a cast without reduction
Study NCT05924321 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbetocin
Description: Single infusion of Carbetocin
Study NCT05924321 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single IV infusion of matching placebo
Study NCT05924321 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo and Moxifloxacin
Description: Single IV infusion of matching placebo in combination with Single Oral dose of Moxifloxacin
Study NCT06581679 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triptorelin
Description: GnRHa will be given as a subcutaneous injection of triptorelin in a dose of 3.75 mg monthly for three months.
Study NCT06581679 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: levonorgestrel-releasing intrauterine system
Description: The levonorgestrel-releasing intrauterine system releasing 20 levonorgestrel daily.
Study NCT06581679 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: frozen embryo transfer
Description: Frozen embryo transfer (FET) where a previously frozen embryo is thawed and transferred into a woman's uterus.~The FET process involves hormone preparation to prepare the uterus for the transfer, embryo thawing, and the actual transfer of the embryo into the uterus. If the embryo implants and develops successfully, pregnancy can occur.
Study NCT06581315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donafenib
Description: Donafenib 100 mg twice daily (BID)
Study NCT05452018 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention group
Description: In healthy volunteers, activity measurement of muscles of interest by intramuscular electromyography during predefined swallowing tasks